Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-132612

SVP & Chief Accounting Officer sold 100,000 shares at $15.09 ($1,509,000)

  • SVP & Chief Accounting Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Thomsen Jillian B. · SVP & Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-11 Exercise or conversion : show line 1 in the form +100,000 $4.65 $465,000 106,809 D
2016-07-11 Sale : show line 2 in the form −100,000 $15.09 $1,509,000 6,809 D
Open-market sales · 100,000 sh · avg $15.09 · $1,509,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-07-11 Exercise or conversion : show line 3 in the form Stock Option −100,000 $4.65 2017-02-22 100,000 0 D
Loading xslF345X03/doc4.xml…